EDGAR Filing Documents for 0001615774-18-005896

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001615774-18-005896

Filing Date

2018-06-28

Accepted

2018-06-28 16:30:21

Documents

Period of Report

2018-06-27

Document Format Files

Seq	Description	Document	Type	Size
1	4	s111090_form4.html	4
1	4	s111090_form4.xml	4	9208
	Complete submission text file	0001615774-18-005896.txt		10695

Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022

Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894

Tonix Pharmaceuticals Holding Corp. (Issuer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TONIX PHARMACEUTICALS HOLDING CORP 509 MADISON AVE., SUITE 306 NEW YORK NY 10022

Business Address

Type: 4 | Act: 34 | File No.: 001-36019 | Film No.: 18925703